Literature DB >> 12529389

Identification of homeodomain proteins, PBX1 and PREP1, involved in the transcription of murine leukemia virus.

Sheng-Hao Chao1, John R Walker, Sumit K Chanda, Nathanael S Gray, Jeremy S Caldwell.   

Abstract

Cyclin-dependent kinase inhibitors (CDKIs) have been shown to block human immunodeficiency virus and herpes simplex virus. It is hypothesized that CDKIs block viral replication by inhibiting transcription of specific cellular genes. Here we find that three CDKIs, flavopiridol, purvalanol A, and methoxy-roscovitine, block Moloney murine leukemia virus (MLV) transcription events. Using gene expression microarray technology to examine the inhibitory effects of CDKIs, we observed a cellular gene, the pre-B-cell leukemia transcription factor 1 (Pbx1) gene, down-regulated by CDKI treatment. The PBX consensus element (PCE), TGATTGAC, is conserved in the long terminal repeats of several murine retroviruses, including Moloney MLV. Mutations in the PCE completely inhibited viral transcription whereas overexpression of PBX1 and a PBX1-associated protein, PREP1, enhanced viral transcription. The interaction between the PCE and PBX1-PREP1 proteins was confirmed by gel shift experiments. Blocking PBX1 protein synthesis resulted in a significant decrease in viral transcription. Collectively, our results represent the first work demonstrating that the homeodomain proteins PBX1 and PREP1 are cellular factors involved in Moloney MLV transcription regulation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12529389      PMCID: PMC140703          DOI: 10.1128/MCB.23.3.831-841.2003

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  53 in total

Review 1.  P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II.

Authors:  D H Price
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

2.  HOXA9 forms triple complexes with PBX2 and MEIS1 in myeloid cells.

Authors:  W F Shen; S Rozenfeld; A Kwong; L G Köm ves; H J Lawrence; C Largman
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

3.  Retroviral cDNA integration: stimulation by HMG I family proteins.

Authors:  L Li; K Yoder; M S Hansen; J Olvera; M D Miller; F D Bushman
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  Flavopiridol inhibits P-TEFb and blocks HIV-1 replication.

Authors:  S H Chao; K Fujinaga; J E Marion; R Taube; E A Sausville; A M Senderowicz; B M Peterlin; D H Price
Journal:  J Biol Chem       Date:  2000-09-15       Impact factor: 5.157

5.  Inhibition of human immunodeficiency virus type 1 transcription by chemical cyclin-dependent kinase inhibitors.

Authors:  D Wang; C de la Fuente; L Deng; L Wang; I Zilberman; C Eadie; M Healey; D Stein; T Denny; L E Harrison; L Meijer; F Kashanchi
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

6.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.

Authors:  S M Elbashir; J Harborth; W Lendeckel; A Yalcin; K Weber; T Tuschl
Journal:  Nature       Date:  2001-05-24       Impact factor: 49.962

Review 7.  Flavopiridol: the first cyclin-dependent kinase inhibitor in human clinical trials.

Authors:  A M Senderowicz
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

8.  High-mobility-group protein I can modulate binding of transcription factors to the U5 region of the human immunodeficiency virus type 1 proviral promoter.

Authors:  A Henderson; M Bunce; N Siddon; R Reeves; D J Tremethick
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

Review 9.  Mechanisms of retrovirus-induced oncogenesis.

Authors:  G Sourvinos; C Tsatsanis; D A Spandidos
Journal:  Folia Biol (Praha)       Date:  2000       Impact factor: 0.906

10.  Inhibition of CDKs as a therapeutic modality.

Authors:  E A Sausville; J Johnson; M Alley; D Zaharevitz; A M Senderowicz
Journal:  Ann N Y Acad Sci       Date:  2000-06       Impact factor: 5.691

View more
  14 in total

1.  Genome-scale functional profiling of the mammalian AP-1 signaling pathway.

Authors:  Sumit K Chanda; Suhaila White; Anthony P Orth; Richard Reisdorph; Loren Miraglia; Russell S Thomas; Paul DeJesus; Daniel E Mason; Qihong Huang; Raquel Vega; De-Hua Yu; Christian G Nelson; Brendan M Smith; Robert Terry; Alicia S Linford; Yang Yu; Gung-wei Chirn; Chuanzheng Song; Mark A Labow; Dalia Cohen; Frederick J King; Eric C Peters; Peter G Schultz; Peter K Vogt; John B Hogenesch; Jeremy S Caldwell
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-26       Impact factor: 11.205

2.  Delayed biosynthesis of varicella-zoster virus glycoprotein C: upregulation by hexamethylene bisacetamide and retinoic acid treatment of infected cells.

Authors:  Johnathan Storlie; Wallen Jackson; Jennifer Hutchinson; Charles Grose
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

3.  Novel neuroprotective GSK-3β inhibitor restricts Tat-mediated HIV-1 replication.

Authors:  Irene Guendel; Sergey Iordanskiy; Rachel Van Duyne; Kylene Kehn-Hall; Mohammed Saifuddin; Ravi Das; Elizabeth Jaworski; Gavin C Sampey; Svetlana Senina; Leonard Shultz; Aarthi Narayanan; Hao Chen; Benjamin Lepene; Chen Zeng; Fatah Kashanchi
Journal:  J Virol       Date:  2013-11-13       Impact factor: 5.103

4.  Prep1/Pbx2 complexes regulate CCL2 expression through the -2578 guanine polymorphism.

Authors:  E K Wright; S H Page; S A Barber; J E Clements
Journal:  Genes Immun       Date:  2008-05-15       Impact factor: 2.676

5.  Effect of mimetic CDK9 inhibitors on HIV-1-activated transcription.

Authors:  Rachel Van Duyne; Irene Guendel; Elizabeth Jaworski; Gavin Sampey; Zachary Klase; Hao Chen; Chen Zeng; Dmytro Kovalskyy; Mahmoud H El Kouni; Benjamin Lepene; Alexis Patanarut; Sergei Nekhai; David H Price; Fatah Kashanchi
Journal:  J Mol Biol       Date:  2012-12-13       Impact factor: 5.469

6.  XBP-1, a novel human T-lymphotropic virus type 1 (HTLV-1) tax binding protein, activates HTLV-1 basal and tax-activated transcription.

Authors:  Sebastian C Y Ku; Jialing Lee; Joanne Lau; Meera Gurumurthy; Raymond Ng; Siew Hui Lwa; Joseph Lee; Zachary Klase; Fatah Kashanchi; Sheng-Hao Chao
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

7.  microRNA machinery is an integral component of drug-induced transcription inhibition in HIV-1 infection.

Authors:  Lawrence Carpio; Zachary Klase; William Coley; Irene Guendel; Sarah Choi; Rachel Van Duyne; Aarthi Narayanan; Kylene Kehn-Hall; Laurent Meijer; Fatah Kashanchi
Journal:  J RNAi Gene Silencing       Date:  2010-05-29

8.  The Ring Finger Protein RNF6 Induces Leukemia Cell Proliferation as a Direct Target of Pre-B-cell Leukemia Homeobox 1.

Authors:  Xin Xu; Kunkun Han; Xiaowen Tang; Yuanying Zeng; Xu Lin; Yun Zhao; Zubin Zhang; Biyin Cao; Depei Wu; Xinliang Mao
Journal:  J Biol Chem       Date:  2016-03-12       Impact factor: 5.157

9.  Roscovitine inhibits activation of promoters in herpes simplex virus type 1 genomes independently of promoter-specific factors.

Authors:  Prerna Diwan; Jonathan J Lacasse; Luis M Schang
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

10.  Ancient, independent evolution and distinct molecular features of the novel human T-lymphotropic virus type 4.

Authors:  William M Switzer; Marco Salemi; Shoukat H Qari; Hongwei Jia; Rebecca R Gray; Aris Katzourakis; Susan J Marriott; Kendle N Pryor; Nathan D Wolfe; Donald S Burke; Thomas M Folks; Walid Heneine
Journal:  Retrovirology       Date:  2009-02-02       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.